+ All Categories
Home > Documents > Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’...

Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’...

Date post: 05-Sep-2019
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
25
!"#$%&’# )%**#+ !"#$%& ( )*+*,-.) "%-*)$/-".%*% 0%& 1"#%$!-)$%1&0/-".% 2.% #!03.3.)-"3."&*%
Transcript
Page 1: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

!!!!!!!!!

!"#$%&'#()%**#+(((

!"#$%&'(')*+*,-.)'"%-*)$/-".%*%''0%&'1"#%$!-)$%1&0/-".%'2.%'#!03.3.)-"3."&*%'

!

!

!!!!!!!!!!!!!!!

Page 2: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

!"#$!"$%&'()$!*#+,#-&)$.!/!012/3#4)$#&'5%645)7$!!!"#$"%&'()"*+,-./0)%'1(2"%0.3-'.3-42*+,-0.!"#$"%2,-5."#$!"$%&'()$!*#+,#-&)$.!8$9:$#()4$&!;#$'$!2%+,#.5&#-4!#4!;$9!"$%&'()$4!<5&#-45,+#+,#-=956#$>!;$&5#,,#$9&$!+#+,#-=956#'()$!"5&$4!'#4;!#7!14&$94$&!?+$9!)&&@ABB;4+C;;+C;$!5+9%6+59C!!

!!!!!!!!!!!!!!!!!!!!!!!!!!D$;9%(.&!5%6!)-,:/!%4;!'E%9$69$#$7!25@#$9F!GHH!I!(),-969$#!=$+,$#()&C!!!!!!!!!J! K$#L$4'$$!M$9,5=F!*$9,#4!NHHN!! K#,)$,7/K5=$46$,;/O&9C!GF!GPHQR!*$9,#4!! S$,C!H!PH!B!TG!NH!U/GHH!! VVVCV$#''$4'$$/8$9,5=C;$!! $/75#,A!75#,WV$#''$4'$$/8$9,5=C;$!!X,,$!Y$()&$!8-9+$)5,&$4!!Z7'(),5=A!0)#,#!D956#./"$'#=4F!*$9,#4F!%4&$9!M$9V$4;%4=!$#4$9!D956#.!;$9!X%&-9#4!!29#4&$;!#4!D$9754[!!!1OO<!GRGG/H\PR!1O*<!P/TP]]UT/Q\/\!!

Page 3: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

'

'''

!"#$%&'(')*+*,-.)'"%-*)$/-".%*%''0%&'1"#%$!-)$%1&0/-".%'2.%'#!03.3.)-"3."&*%'

(

(

(

(

(

(

(

(

"%$0#0)$!4&"11*)-$-".%'(

,-+(.+/%&0-&0(1#+(234"3+56+1#((

%*(7%89:#+#'89(;'3/30'#<(=9#*'#<(>9%+*%,'#(

(1#+(7+#'#&(?&'@#+A'"B"(;#+/'&(

(

(

@3+0#/#0"(@3&(

156789:6';8<<6='%-A(C-15'0A9%$#&(%*(D9#'&(

(

(

;#+/'&(EFFE

Page 4: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

&$%/1$#0%#' ' 2""'

7+%-(>+3$G(2+G(H3&'4%(!89B$#+IJ3+"'&0(1%&4#( '89(A#9+(9#+,/'89( $6+(1'#(K#+0%:#(1#A(

'&"#+#AA%&"#&(2'AA#+"%"'3&A"9#*%A<(1'#(5'AA#&A89%$"/'89#&(L&+#0-&0#&<(1'#(A"B&1'0#(

M#AN+B89A:#+#'"A89%$"(-&1('9+#($O+1#+&1#(?&"#+A"6",-&0G(

(

H#'&( :#A3&1#+#+( 2%&4( 0'/"( )#++&( >+3$G( 2+G( )%&AI2'#"#+( )O/"P#<( )#'&+'89I)#'&#I

?&'@#+A'"B"(26AA#/13+$<($6+(1'#($+#-&1/'89#(L&/#'"-&0(:#'(1#&(H3/#8-/%+(H31#//'&0(?&I

"#+A-89-&0#&<( 1'#( A"B&1'0#(M#AN+B89A:#+#'"A89%$"( :#'( 1#+( K#+O$$#&"/'89-&0( 1#+( .+I

0#:&'AA#(-&1(1'#(L&$#+"'0-&0(1#A(Q5#'"0-"%89"#&AG((

(

;#A3&1#+A(1%&4#&(*O89"#( '89(%-89(%//#&(H'"0/'#1#+&(1#A(L+:#'"A4+#'A#A(@3&()#++&(

>+3$G(2+G()%&AI2'#"#+()O/"P#( $6+(1'#($+#-&1/'89#(L-$&%9*#(-&1(1'#(0+3R#()'/$A:#+#'"I

A89%$"<( '&A:#A3&1#+#( )#++&( 2+G( S3/$0%&0( !'NN/( $6+( 1'#( ;#"+#--&0( 1#+( T!LDI

?&"#+A-89-&0#&(-&1(1'#(2-+89A'89"(1#+(L+:#'"(A35'#(7+%-(M'A#/%(U#AA#&($6+(1'#(J3I

3N#+%"'3&(-&1(1'#(@'#/#&($6+(*'89(-*0#B&1#+"#&(L::'/1-&0#&G(

(

H#'&(2%&4(0'/"(%-89()#++&(>+3$G(2+G(V/'@#+(C'#A#&$#/1($6+(1'#(W:#+/%AA-&0(1#+()'+&#&I

13"9#/,#//#&(A35'#()#++&(2+G(.-/#<()#++&(2+G(U-&0<()#++&(2+G(J&3:/%-89(-&1()#++&(

2+G(!89'/14&#89"($6+(1%A(M#5#:#*%"#+'%/(,-+(Q#//0#5'&&-&0G(

(

;#'()#++&(U6+0#&(S'//#+"<(H%XI>/%&84IY&A"'"-"( $6+(H3/#4-/%+#(M#&#"'4(;#+/'&<(*O89"#(

'89(*'89(9#+,/'89($6+(1'#(L&/#'"-&0(:#'(1#+(>/%A*'1%*N/'$','#+-&0(:#1%&4#&G((

(

7+%-(2'%&%(;#9+#&A(-&1()#++&(2+G(H'89%#/(;#84#+(%-A(1#+(M+-NN#(@3&(7+%-(2+G(Y1-I

&%( 7'89"&#+<( H%XI2#/:+684IQ#&"+-*( ;#+/'&<( 1%&4#( '89( $6+( 1'#( J33N#+%"'3&( :#'( 1#+((

."%:/'#+-&0(1#+(DZI>=DG(

(

L//#&( H'"0/'#1#+&( 1#A( L+:#'"A4+#'A#A( @3&( 7+%-( >+3$G( 2+G( H3&'4%( !89B$#+IJ3+"'&0(

*O89"#('89($6+(1%A($+#-&1A89%$"/'89#(L+:#'"A4/'*%(-&1(1'#(@'#/#&("3//#&(0#*#'&A%*#&(

?&"#+&#9*-&0#&( 1%&4#&G( ;#A3&1#+#+( 2%&4( 0'/"( 9'#+( 7+%-( Y+'&%( !N'4%( $6+( 1'#( #&0#(

Q-A%**#&%+:#'"( %/A(M/-8383+"'83'10+-NN#(-&1(1'#(N#+AO&/'89#(7+#-&1A89%$"<()#++&(

>2(2+G(;-+49%+1(J/#-A#+( $6+( 1'#(5'AA#&A89%$"/'89#(;#+%"-&0<( 1'#( 4+'"'A89#&(2'A4-AI

A'3&#&(-&1(1'#(J3++#4"-+(1#+(L+:#'"<(7+%-(2+G(?/+'4#(Z+'#+( $6+(1'#(L-$*-&"#+-&0(-&1(

;#"+#--&0( ,-( ;#0'&&( 1#+( >+3*3"'3&( A35'#( 7+%-( 2+G( L&&#4%"9+'&( )%:#+/%&1( -&1(

)#++&(?5#(H6&A"#+($6+(1'#(J3++#4"-+(1#+(L+:#'"G(

Page 5: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

,0>!"/$-".%12*)+*"3;%"1' ' "?'

.=:@:98A8=B6:569'')G([-<( UG(7+%&4<(?G(Z+'#+<(!G()%**#+<(SG(!89+O1#+<( UG(;#9/4#<(HG(!89B$#+IJ3+"'&0<(

UG7G( )3/,5%+"9<( SG( !B&0#+\( Y&"#+%8"'3&( 3$( 7/-3+#A8#&8#( C%:#/#1( !'&0/#I!"+%&1#1(

2]L(5'"9()#X%*#+'8(2]LI)#/'8%A#(D#NL\(L(>93"3&(%&1(7/-3+#A8#&8#(=3++#/%"'3&(

!N#8"+3A83N^(!"-1^G(;'389#*'A"+^(_F\(`EaaI`Eab<(EFFa(

(

!G()%**#+<( YG(!N'4%<( SG(!'NN/<( MG(U#AA#&<( ;G(J/#-A#+<( )GI2G()O/"P#<( HG(!89B$#+I

J3+"'&0\( M/-8383+"'83'1( D#8#N"3+( Y&"#+%8"'3&A( 5'"9( M/-8383+"'83'1A\( .@%/-%"'3&( :^((

H3/#8-/%+( H31#/'&0( %&1( 7-&8"'3&%/( L&%/^A'A( 3$( M/-8383+"'83'1( D#8#N"3+( H-"%&"AG((

!"#+3'1A<(+#@'#5#1(

(

YG(!N'4%<(!G()%**#+<(;G(J/#-A#+<()GI=G(J3+"'&0<(HG(!89B$#+IJ3+"'&0\(Z+%&A8+'N"'3&%/(

L8"'@'"^( 3$( >3"#&"( M/-8383+"'83'1A\( D#/#@%&8#( 3$( M/-8383+"'83'1( D#8#N"3+( YA3$3+*A(

%&1(2+-0(H#"%:3/'"#AG(!4'&(>9%+*%83/30^(%&1(LNN/'#1(!4'&(>9^A'3/30^<('*(2+-84(

(

?G( H6&A"#+<( !G( )%**#+<( ?G( ;/-*#I>#^"%@'<( HG( !89B$#+IJ3+"'&0\( Z#A"3A"#+3&#( *#I

"%:3/'A*( '&( 9-*%&( A4'&( I( '&$/-#&8#( 3$( 1+-0AG( !4'&( >9%+*%83/30^( %&1(LNN/'#1( !4'&(

>9^A'3/30^<(#'&0#+#'89"(

(

(

,CD56=''LG(M^A/#+<( !G()%**#+<(?G( JO&'0A*%&&<(=G(!%&"3A(H%'%<(HG(!89B$#+IJ3+"'&0\(2+-0(

>#&#"+%"'3&(%&1(H#"%:3/'A*('&()-*%&(!4'&(H31#/AG(!^*N3A'-*(cQ.;.ZdA(aF(e#%+(

L&&'@#+A%+^c<(;0KK<(;#+/'&<(afff(

(

!G()%**#+<(YG(!N'4%<(?G(Z+'#+<(;G(J/#-A#+<(HG(!89B$#+IJ3+"'&0\(M/-8383+"'83'1(D#8#NI

"3+(L/N9%(%&1(;#"%\(!'0&%/(Z+%&A1-8"'3&(%&1(H-"-%/(Y&$/-#&8#G(L+89(>9%+*(g!-NN/(Eh(

iii<(EFFF(

(

?G(H6&A"#+<(!G()%**#+<(HG(!89B$#+IJ3+"'&0\(Z#A"3A"#+3&#(*#"%:3/'A*('&(9-*%&(A4'&(

%&1('"A('&9':'"'3&(:^(a`!I#A"+%1'3/(%&1(1-"%A"#+'1#G(L+89(>9%+*(g!-NN/(Eh(iii<(EFFF(

Page 6: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

?' ' ,0>!"/$-".%12*)+*"3;%"1'

YG( !N'4%<( !G( )%**#+<( ;G( J/#-A#+<( HG( !89B$#+IJ3+"'&0\( Z+%&A%8"'@%"'3&( Y&1-8#1( :^(

Z3N'8%/( M/-8383+"'83'1AG( ]%-&^&I!89*'#1#:#+0dA( L+89( >9%+*%83/( g!-NN/( _h( iji<(

EFFa(

(

?G( H6&A"#+<( !G( )%**#+<( ?G( ;/-*#I>#^"%@'<( HG( !89B$#+IJ3+"'&0\( Z#A"3A"#+3&#( *#I

"%:3/'A*('&(9-*%&(A4'&(I('&9':'"3+^(#$$#8"A(3$(a`!I#A"+%1'3/(%&1(1-"%A"#+'1#G(_"9(Y&"#+I

&%"'3&%/(Y&"#&A'@#(=3-+A#(%&1(S3+4A93N(3&(=#//(=-/"-+#(%&1('&(@'"+3(H31#/A($3+(2+-0(

L:A3+N"'3&(%&1(2#/'@#+^<(!%%+:+684#&<(EFFE(

(

!G()%**#+<( YG( !N'4%<(MG( U#AA#&<()GI2G()O/"P#<(HG(!89B$#+IJ3+"'&0\(M/-8383+"'83'1( I(

D#8#N"3+(Y&"#+%8"'3&A\(.@%/-%"'3&(:^(H3/#8-/%+(H31#/'&0(%&1(Z+%&A%8"'@%"'3&(3$(S'/1(

Z^N#( %&1( H-"%&"( D#8#N"3+AG( ]%-&^&I!89*'#1#:#+0dA( L+89( >9%+*%83/( g!-NN/(ah(

ijk<(EFFE(

(

YG( !N'4%<( !G( )%**#+<( HG( !89B$#+IJ3+"'&0\( )'09( Z+%&A+#N+#AA'@#( L8"'3&( 3$( ]%"'@#(

>+#1&'8%+:%"#G(]%-&^&I!89*'#1#:#+0dA(L+89(>9%+*%83/(g!-NN/(ah(ijk<(EFFE(

(

!G()%**#+<(YG(!N'4%<(SG(!'NN/<(MG(U#AA#&<()GI2G()O/"P#<(HG(!89B$#+IJ3+"'&0\(M/-8383+I

"'83'1( D#8#N"3+( Y&"#+%8"'3&A\( H3/#8-/%+( H31#/'&0( %&1( T!LD( Y&@#A"'0%"'3&A<( L+89(

>9%+*(g!-NN/(ah 335<(EFFE(

(

(

'

Page 7: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

"%;$!-12*)+*"3;%"1' ' ?"'

E'*"%!*"-0%# FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFE!

EFE!15=GH5G='G9I'!:@89I69B:9IG9@'I6D'#AGJCJC=5:JC:I4)6K6L5C=D FFFFFFFFFFFFFFFFFFFFF M!aGaGa!7-&4"'3&#//#(23*B&#&(1#A(M/-8383+"'83'1ID#,#N"3+AGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG i!

aGaGE!!"+-4"-+(1#+(C'0%&1#&:'&1-&0A13*B&# GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG k!

aGaGi! Y&"#+%4"'3&#&(*'"(1#*(C'0%&1#& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG j!

aGaG_!!"+-4"-+lS'+4-&0AI;#,'#9-&0#&(1#+(M/-8383+"'83'1# GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG `!

EFN!1:@98A5=89DIGH5:C9'OB6='I69'#AGJCJC=5:JC:I4)6K6L5C= FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF P!aGEGa!Z+%&A4+'N"'3&#//#(L4"'@'#+-&0(-&1()#**-&0(@3&(M#&#&(1-+89(2]LI

;'&1-&0(1#A(M/-8383+"'83'1ID#,#N"3+A GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG f!

aGEGE!)#**-&0(@3&(Z+%&A4+'N"'3&A$%4"3+#&(1-+89(1#&(M/-8383+"'83'1I

D#,#N"3+(gZ+%&A+#N+#AA'3&hGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG aE!

EFM!#AGJCJC=5:JC:I4)6K6L5C=41GB5QL69 FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF ER!EFR!#AGJCJC=5:JC:I6':9'I6='&6=<85CAC@:6FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF ES!

aG_Ga!2%A(%"3N'A89#(.4,#*GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG a`!

aG_GE!M/-8383+"'83'1IZ9#+%N'#(1#A(%"3N'A89#&(.4,#*AGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG ab!

aG_Gi!]-",#&lD'A'43I;#5#+"-&0GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG EF!

EFT!U=8@6D56AAG9@'G9I'+:6AD65KG9@FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF NE!

N'V$-*)"$!'0%&'V*-;.&*%FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFNT!

NFE!V856=:8A FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF NS!EGaGa!M#+B"# GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG E !̀

EGaGE!D#%0#&,'#&(-&1(K#+:+%-89A*%"#+'%/'#& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Eb!

EGaGi!M/-8383+"'83'1ICOA-&0#&GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG ia!

NFN!+6AAHGA5:W:6=G9@'G9I'-=89D76H5:C969 FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF MN!EGEGa!J-/"'@'#+-&0(@3&(N+'*B+#&(J#+%"'&3,^"#&(-&1(7':+3:/%A"#& GGGGGGGGGGGGGGGGGGGGGGG iE!

EGEGE!J-/"'@'#+-&0(@3&(=V!I`IQ#//#&(-&1(9-*%&#&()'+&#&13"9#/,#//#&GGGGGGGGGGGGG ii!

EGEGi!.XN+#AA'3&AN/%A*'1#<(>/%A*'1%*N/'$'4%"'3&(-&1(D#A"+'4"'3&A%&%/^A# GGGGGGG i_!

EGEG_!Z+%&A$#4"'3&(@3&(=V!I`IQ#//#& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG ij!

EGEGk!;#A"'**-&0(1#+(Z+%&A$#4"'3&A#$$','#&,GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG ij!

NFM!#AGJCJC=5:JC:I4)6K6L5C=',=C56:9'G9I'<)%$ FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF MX!EGiGa!>+3"#'&:#A"'**-&0 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG ib!

Page 8: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

?""' ' "%;$!-12*)+*"3;%"1'

EGiGE!!N#,'$'A89#(>+3"#'&1#"#4"'3&(*'""#/A(!2!IM#/#/#4"+3N93+#A#(-&1(

S#A"#+&I;/3"GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG ib!

EGiGi!L&%/^A#(1#+(*D]LIZ+%&A4+'N"'3&\(*D]LIYA3/'#+-&0<(82]LI!^&"9#A#(

-&1(>3/^*#+%A#4#""#&+#%4"'3& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG _F!

NFR!)6K6L5C=B:9IG9@'G9I'5=89DH=:L5:C96AA6'$H5:W:6=G9@ FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF RM!EG_Ga!D#,#N"3+:'&1-&0AA"-1'#&(%&('&"%4"#&(Q#//#&GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG _i!

EG_GE!Q^"3A3/'A89#(D#,#N"3+:'&1-&0AA"-1'#&GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG __!

EG_Gi!;#A"'**-&0(1#+("+%&A4+'N"'3&#//#&(L4"'@'#+-&0GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG _k!

NFT!>6D5:<<G9@'I6='$LCL5CD6=856 FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF RY!EGkGa!Q#//A"'*-/%"'3&(-&1(m%-$%+:#'"-&0GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG _`!

EGkGE!.'&A"#//-&0(1#A(2-+89$/-AA,^"3*#"#+A(-&1(H#AA-&0 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG _`!

NFY!-Z6C=65:DJZ6'3Z8=8H56=:D:6=G9@'I6='#AGJCJC=5:JC:I'4')6K6L5C='[6JZD6A\:=HG9@69 FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF RP!EGjGa!J+%$"$#/1IH#"931#&GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG _f!

EGjGE!J3&$3+*%"'3&A%&%/^A#&GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG kF!

EGjGi!H3/#46/1^&%*'4I!'*-/%"'3&#&GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG kF!

EGjG_!H#"931#&(,-+(M#3*#"+'#3N"'*'#+-&0 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG ka!

EGjGk!=9%+%4"#+'A'#+-&0(1#+(>+3"#'&A"+-4"-+GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG kE!

EGjGj!T-%&"'"%"'@#(!"+-4"-+lS'+4-&0AI;#,'#9-&0#&GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG kE!

NFS!1585:D5:HFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF TR!

M'*)#*>%"11*FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFTT!

MFE!*]L6=:<6956AA6'>6D5:<<G9@'I6=')6K6L5C=B:9IG9@'WC9'#AGJCJC=5:JC:I69F TS!iGaGa!D#,#N"3+:'&1-&0AA"-1'#&(%&(=V!I`IQ#//#&GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG k`!

iGaGE!D#,#N"3+:'&1-&0AA"-1'#&(%&(7':+3:/%A"#& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG jk!

MFN!-Z6C=65:DJZ6'0956=DGJZG9@69'KG=')6K6L5C=B:9IG9@'WC9'#AGJCJC=5:JC:I69 FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF YY!iGEGa!!'*-/%"'3&(1#+(C'0%&1#&:'&1-&0 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG j`!

iGEGE!=9%+%4"#+'A'#+-&0(1#+(C'0%&1ID#,#N"3+IJ3*N/#X#\(H3/#46/1^&%*'4I

!'*-/%"'3&#&GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG jf!

iGEGi!T-%&"'"%"'@#(!"+-4"-+lS'+4-&0AI;#,'#9-&0#&GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG `i!

MFM!UG9H5:C96AA6'3Z8=8H56=:D:6=G9@'WC9'Z#)!4VG589569FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF SS!

iGiGa!C'0%&1#&:'&1-&0(1-+89(9MD!IH-"%&"#& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG ``!

Page 9: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

"%;$!-12*)+*"3;%"1' ' ?"""'

iGiGE!Z+%&A4+'N"'3&#//#(L4"'@'#+-&0(1-+89(9MD!IH-"%&"#&GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG `f!

MFR!>6I6G5G9@'I6D'#AGJCJC=5:JC:I4)6K6L5C=41GB5QLD'Z#)" FFFFFFFFFFFFFFFFFFFFFFFFFFFFF XE!

iG_Ga!K3+43**#&(@3&(9MD"('&(J#+%"'&3,^"#&(-&1(7':+3:/%A"#&GGGGGGGGGGGGGGGGGGGGGGGG bE!

iG_GE!.'&$/-AA(@3&(9MD"(%-$(1'#(!'0&%/6:#+"+%0-&0(1-+89(9MD! GGGGGGGGGGGGGGGGGGGGGG b`!

MFT!*:97AGDD'WC9'#AGJCJC=5:JC:I69'8G7'I:6'$LCL5CD6FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF PE!iGkGa!LN3N"3"'A89#(S'+4-&0(%-$(J#+%"'&3,^"#&(-&1(7':+3:/%A"#& GGGGGGGGGGGGGGGGGGGGGGG fa!

iGkGE!L&"'%N3N"3"'A89#(S'+4-&0(%-$(J#+%"'&3,^"#&(-&1(7':+3:/%A"#& GGGGGGGGGGGGGGGGG fE!

iGkGi!;##'&$/-AA-&0(1#+(LN3N"3A#(@3&()'+&#&13"9#/,#//#& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGG aFF!

R'&"1/011".%FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFE^M!

RFE!*]L6=:<6956AA6'0956=DGJZG9@'I6=')6K6L5C=B:9IG9@'WC9'#AGJCJC=5:JC:I69 FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF E^T!

RFN!-Z6C=65:DJZ6'>65=8JZ5G9@'I6='#AGJCJC=5:JC:I4Z#)!'[6JZD6A\:=HG9@69 E^S!

RFM!!:@89I69B:9IG9@'G9I'1:@98A5=89DIGH5:C9'WC9'Z#)!4VG589569FFFFFFFFFFFFFFFF EE^!RFR!*:97AGDD'WC9')6K6L5C=41GB5QL69FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF EEM!RFT!*:97AGDD'WC9'#AGJCJC=5:JC:I69'8G7'I:6'$LCL5CD6FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF EEY!RFY!$GDBA:JHFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF EEP!

T'+01$VV*%U$110%#FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFENE!

Y'!"-*)$-0)2*)+*"3;%"1FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFENS!

Page 10: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

$>/_)+0%#12*)+*"3;%"1' ' ?2'

L8#"^/I=3(L( L8#"^/I=3#&,^*(L(

L8"( L8"'&3*^8'&(2(

L7( Z+%&A%4"'@'#+-&0AI23*B&#(

L/%<(L( L/%&'&(

L*N+( L*N'8'//'&+#A'A"#&,(

L>Ia( L4"'@%"3+N+3"#'&Ia(

LD( L&1+30#&ID#,#N"3+(

L+0<(D( L+0'&'&(

LA&<(]( LAN%+%0'&(

;8/IE( )-*%&#A(;IQ#//IC^*N93*I>+3"33&430#&IE(

;H( ;#"%*#"9%A3&(

;H2>( ;#"%*#"9%A3&Ia`<EaI1'N+3N'3&%"(

;HK( ;#"%*#"9%A3&Ia`I@%/#+%"(

;>.( ;3@'&#+()^N3N9^A#&#X"+%4"(

;!L( ;3@'&#A(!#+-*%/:-*'&(

;Z7( ;%A%/#(Z+%&A4+'N"'3&A$%4"3+#&(

=l.;>( ==LLZl.&9%&8#+I;'&1'&0I>+3"#'&(

=EI=#+( ]IL8#"^/I2I#+^"9+3I!N9'&03A'&(

=LZ( =9/3+%*N9#&'83/IL8#"^/"+%&A$#+%A#(

=;>( =D.;I;'&1'&0I>+3"#'&(

=2( 2'$$#+#&,'#+-&0A*%+4#+(g8/-A"#+(3$(1'$$#+#&"'%"'3&h(

=C>( =/3:#"%A3/Ia`IN+3N'3&%"(

=HK( Q^"3*#0%/'#IK'+-A(

=3H7L( =3*N%+%"'@#IH3/#8-/%+I7'#/1IL&%/^A'A(

=V[IE( =^8/33X^0#&%A#IE(

8N*( QB9/+%"#(g83-&"A(N#+(*'&-"#h(

=D.;( 8LH>ID#AN3&A#I./#*#&"I;'&1-&0A$%4"3+(

=K77( =3&A'A"#&"IK%/#&8#I73+8#I7'#/1(

2;2( 2]LI;'&1-&0A13*B&#(

2=.( 2#A3X'*#"%A3&IEaI8'&&%*%"(

2.>=( 2'#"9^/N^+38%+:3&%"(

2.[( 2#X%*#"9%A3&(i)I2.[( na<E<_<j<`Ii)o(2#X%*#"9%A3&(

2H.H( 2-/:#883pA(H31'$'#1(.%0/#Ap(H#1'-*(

2H!( ]<]I2'*#"9^/I2I#+^"9+3I!N9'&03A'&(

2H!V( 2'*#"9^/A-/$3X'1(

Page 11: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

?2"' ' $>/_)+0%#12*)+*"3;%"1'

2VH( 2#A3X'*#"%A3&(

2ZZ( 2'"9'3"9+#'"3/(

.=kFZL( )%/:*%X'*%/#(Z+%&A%4"'@'#+-&0A5#+"#(

.2ZL( ."9^/#&1'%*'&"#"+%#AA'0AB-+#(

.D( .A"+30#&ID#,#N"3+(

]7LZ( ]-8/#%+I7%8"3+I3$IL8"'@%"#1IZI=#//A(

.";+( ."9'1'-*:+3*'1(

7L=!( 2-+89$/-AA,^"3*#"#+(g7/-3+#A8#&8#(L8"'@%"#1(=#//(!3+"'&0h(

7;H( 7':+3:/%A"#&I;%A%/*#1'-*(

7MH( 7':+3:/%A"#&IS%89A"-*A*#1'-*(

7YZ=( 7/-3+#A8#'&'A3"9'38^%&%"(

7J!( 7#"%/#A(JB/:#+A#+-*(

7!=( 73+5%+1A8%""#+(

q(0( D#/%"'@#(Q#&"+'$-0%/:#A89/#-&'0-&0(

"IM%/( "IM%/%8"3A'1%A#(

M/&<(T( M/-"%*'&(

M/-<(.( M/-"%*%"(

MHI=!7( M+%&-/3,^"#&lH%4+3N9%0#&IJ3/3&'#A"'*-/'#+#&1#+(7%4"3+(

MD( M/-8383+"'83'1ID#,#N"3+(

MD.( M/-8383+"'83'1ID#AN3&A#I./#*#&"(

);H.=( )-*%&#(*'4+3@%A4-/B+#()'+&#&13"9#/,#//#&(

9.M7(( )-*%&#+(.N'1#+*%/#+(S%89A"-*A$%4"3+(

)D>( H##++#""'89I>#+3X'1%A#(

9AN( )'",#A89384N+3"#'&(

)?K.=( )-*%&#(@#&OA#(]%:#/A89&-+#&13"9#/,#//#&(

Y=kF#XN( .XN#+'*#&"#//#(9%/:*%X'*%/#(K#+1+B&0-&0A5#+"#(

Y=kFN+#1( K3+9#+0#A%0"#(9%/:*%X'*%/#(K#+1+B&0-&0A5#+"#(

Y=LHIa( Y&"+%8#//-/%+IL19#A'3&IH3/#8-/#Ia(

Y2( Y**-&30#&#(23*B&#(

Y0I.( Y**-&0/3:-/'&I.(

YC( Y&"#+/#-4'&(

Y#;!( Y&9':'"3+N+3"#'&(1#A(]7#;(

JL( J3%4"'@%"3+(

J;H( J#+%"'&3,^"#&I;%A%/*#1'-*(

J2( 2'AA3,'%"'3&A43&A"%&"#(

J2%( J'/3(2%/"3&(

Page 12: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

$>/_)+0%#12*)+*"3;%"1' ' ?2""'

JMH( J#+%"'&3,^"#&IS%89A"-*A*#1'-*(

JD( J3+#N+#AA3+(

C;2( C'0%&1#&:'&1-&0A13*B&#(

CC&C( ]IL8#"^/IC#-8'&^/IC#-8'&^/I]3+/#-8'&%/(

CVV( C#%@#IV&#IV-"(

H=>( H3&38^"#I=9#*3%""+%8"%&"I>+3"#'&(

H#"<(H( H#"9'3&'&(

H7( H3*#"%A3&Ia`I$-+3%"(

HHZK( H3-A#IH%**%/'%&IZ-*3+IK'+-A(

H>a`>( H#"9^/N+#1&'A3/3&Ia`IN+3N'3&%"(

H>L( H#"9^/N+#1&'A3/3&%8#N3&%"(

H>2( H#"9^/N+#1&'A3/3&(

H>DVML( H#1+3X^N+30#A"#+3&%8#"%"(

HD( H'&#+%/383+"'83'1ID#,#N"3+(

HS( H'""#/5#+"(

]J#;( ]-4/#B+#+(7%4"3+(#(;(

V8"Ia( V8"%*#+IZ+%&A4+'N"'3&AI7%4"3+Ia(

V]>M( 3I]'"+3N9#&^/I"I2IM%/%8"3N^+%&3A'1(

V+'( D#N/'4%"'3&A-+AN+-&0(

>a`.=( >+#1&'A3/3&Ia`I#"9^/8%+:3&%"(

>Ea.=( >+#1&'A3/3&IEaI#"9^/8%+:3&%"(

!ZLZIk( !'0&%/IZ+%&A1-8#+I%&1IL8"'@%"3+I3$IZ+%&A8+'N"'3&Ik(

>L7( >/B""89#&I%4"'@'#+#&1#+I7%4"3+(

>;!( >93AN9%"0#N-$$#+"#I!%/,/OA-&0(

>;!Z( >;!IZ5##&(

>=( >+#1&'8%+:%"(

>2( >+#1&'A3/3&(

>.>( >+#1&'A3/3&Ia`I#"9^/8%+:3&%"<(EaIN9#&^/%8#"%"(

>Y( >+3N'1'-*'31'1(

>C!( >%+"'%/IC#%A"I!r-%+#A(

>>LD( >#+3X'A3*I>+3/'$#+%"3+IL4"'@%"3+ID#,#N"3+(

>D( >+30#A"#+3&ID#,#N"3+(

>!( >93AN9%"'1^/A#+'&(

i2(T!LD( 2+#'1'*#&A'3&%/#(!"+-4"-+lS'+4-&0AI;#,'#9-&0#&(

DLD( D#"'&AB-+#ID#,#N"3+(

D;L( +#/%"'@#(;'&1-&0A%$$'&'"B"(

Page 13: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

?2"""' ' $>/_)+0%#12*)+*"3;%"1'

DH!( D33"IH#%&I!r-%+#<(S-+,#/(1#+(L:5#'89-&0Ar-%1+%"#(

D!K( D3-AI!%+83*%IK'+-A(

DZI>=D( D#@#+A#IZ+%&A4+'N"%A#I>3/^*#+%A#4#""#&+#%4"'3&(

D?_bj( H'$#N+'A"3&(

D[D( D#"'&3'1I[ID#,#N"3+(

!2( !"%&1%+1%:5#'89-&0(

!2.>( !"%&1%+1$#9/#+(1#+(K3+9#+A%0#(

!2!( ]%"+'-*131#8^/A-/$%"(

!.DH( !#/#4"'@#(.A"+30#&ID#,#N"3+IH31-/%"3+#&(

!CQ( !-/$%A%/%,'&(

!D=Ia( !"#+3'1ID#8#N"3+I=3%8"'@%"3+Ia(

!!=( !'1#5%+1A8%""#+(

!K(_F( !'*'%&(K'+-A(_F(

ZL7( Z;>ILAA3,''#+"#+I7%4"3+(Z;.( Z+'AI;3+%"I.2ZL(

Z;>( ZLZLI;'&1-&0AI>+3"#'&(

Z.( Z+'AI.2ZL(

Z7H( Z+%&A$#4"'3&A*#1'-*(

ZY7IE( Z+%&A8+'N"'3&$%8"3+IY&"#+*#1'%+^I7%8"3+IE(

Z]7!( Z-*3+&#4+3A#4$%4"3+(!(

Z>L( >93+:3/IaEI*^+'A"%"<(aiI%8#"%"(

ZD( Z9^+3'1ID#,#N"3+(

Z+'A( Z+'A9^1+3X^*#"9^/%*'&3*#"9%&(

K%/<(K( K%/'&(

K2D( K'"%*'&(2ID#,#N"3+(

5"I9MD!( 5'/1I"^N#I9MD!(

XI0%/( iIY&13/^/I"I2IM%/%8"3N^+%&3A'1(

( (

Page 14: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

'

'

'

'

'

'

'

'

'

'

'

'

E'*"%!*"-0%#'

Page 15: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

E'*"%!*"-0%#' ' M'

EFE' 15=GH5G=' G9I' !:@89I69B:9IG9@' I6D' #AGJCJC=5:JC:I4)6K6L5C=D'

(

2'#( *#'A"#&( :#4%&&"#&( .$$#4"#( &%"6+/'89#+( -&1( A^&"9#"'A89#+( M/-8383+"'83'1#( :#'*(

H#&A89#&(5#+1#&(6:#+(1#&(-:'r-'"B+(@3+43**#&1#&(!I!-:"^N(1#A(9-*%&#&(M/-83I

83+"'83'1ID#,#N"3+A(gMDh<(9MD!<(#'&('*(Q^"3A3/(/34%/'A'#+"#A(8%G(f_(42%(0+3R#A(>+3I

"#'&(@#+*'""#/"( g)3//#&:#+0(#"(%/G<(afbkhG( Y&,5'A89#&(5-+1#&(%-89(*#*:+%&A"B&1'0#(

MD( #&"1#84"( gM%*#"89-( #"( %/G<( afffh<( 6:#+( 1#+#&( 7-&4"'3&A5#'A#( -&1( ;#1#-"-&0(

P#1389( &389( A#9+( 5#&'0( :#4%&&"( 'A"G( 9MD!( 0#9O+"( ,-+( 7%*'/'#( 1#+( !"#+3'193+*3&I

D#,#N"3+#&<(1'#(%&(#'&#+(K'#/,%9/(@3&(7-&4"'3&#&( '*(V+0%&'A*-A(5'#()3*O3A"%A#<(

2'$$#+#&,'#+-&0<( .&"5'84/-&0<( 73+"N$/%&,-&0( -&1( H#"%:3/'A*-A( :#"#'/'0"( A'&1G( Q-+(

7%*'/'#( 1#+( !"#+3'193+*3&ID#,#N"3+#&( 0#9O+#&( &#:#&( MD( H'&#+%/383+"'83'1I

D#,#N"3+#&( gHDh<( L&1+30#&ID#,#N"3+#&( gLDh<( >+30#A"#+3&ID#,#N"3+#&( g>Dh( -&1(

.A"+30#&ID#,#N"3+#&( g.Dh<( @3&( 1#&#&( P#5#'/A( *'&1#A"#&A( E( YA3$3+*#&( 0#$-&1#&(

5-+1#&G(L//#(!"#+3'193+*3&ID#,#N"3+#&(5#'A#&(#'&#(0#*#'&A%*#(1+#'"#'/'0#(!"+-4"-+(

%-$( -&1( 5'+4#&( %/A( /'0%&1#&%:9B&0'0#( Z+%&A4+'N"'3&A$%4"3+#&( g)3//#&:#+0( #"( %/G<(

afbbs(H%&0#/A13+$(#"(%/G<(affkhG((

2'#( !"#+3'193+*3&ID#,#N"3+#&( ,B9/#&( %-$0+-&1( '9+#+( A"+-4"-+#//#&( t9&/'894#'"( ,-I

A%**#&(*'"(1#&(!89'/11+6A#&93+*3&I( gZ9^+3'1Ih(D#,#N"3+#&( gZDh<(1#&(K'"%*'&(2I

D#,#N"3+#&( gK2Dh<( 1#&( D#"'&3'1ID#,#N"3+#&<( 1#&( >#+3X'A3*I>+3/'$#+%"3+IL4"'@%"3+I

D#,#N"3+#&( g>>LDh( -&1( 1#&( V+N9%&ID#,#N"3+#&( ,-+( !-N#+$%*'/'#( 1#+( &-4/#B+#&(

D#,#N"3+#&G( Y&(1#&( /#","#&(U%9+#&(5-+1#&(@'#/#(&#-#(V+N9%&ID#,#N"3+#&(#&"1#84"<(

$6+(1'#( P#1389(:'A9#+( 4#'&#(#&130#&#&(C'0%&1#&( '1#&"'$','#+"(53+1#&(A'&1( gM'0-#+#<(

afffs(!/%1#4(#"(%/G<(EFFFhG((

(

(

EFEFE'UG9H5:C96AA6'&C<`969'I6D'#AGJCJC=5:JC:I4)6K6L5C=D'

(

2'#(#'&,#/&#&(7-&4"'3&#&(1#A(9MD!(4O&&#&(:#A"'**"#&(23*B&#&(,-0#3+1&#"(5#+I

1#&( gL::G( ahG( 2#+( %-A( _if( L*'&3AB-+#&( :#A"#9#&1#( ]I"#+*'&%/#( L:A89&'""( 1#A(

9MD!('A"(%&(1#+(L4"'@'#+-&0(1#+(Z+%&A4+'N"'3&(:#"#'/'0"(-&1(5'+1(1%9#+(%/A(Z+%&A%4"'I

Page 16: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

R'' ' E'*"%!*"-0%#'

@'#+-&0A13*B&#( gL7Iah( 31#+(5#0#&( A#'&#+( A"%+4#&( %&"'0#&#&(>3"#&,( %-89( %/A( '*I

*-&30#&#(23*B&#(gY2h(:#,#'89&#"G(S'89"'0( $6+(1'#(Z+%&A%4"'@'#+-&0(A'&1(#&"5#1#+(

1'+#4"#(S#89A#/5'+4-&0#&(*'"(:%A%/#&(Z+%&A4+'N"'3&A$%4"3+#&(31#+(.'&$/6AA#(%-$(-&I

"#+A"6",#&1#(J3%4"'@%"3+#&(g73+1(#"(%/G<(aff`s()#&+'4AA3&(#"(%/G<(aff`hG(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

2#+(,#&"+%/#<(%-A(,5#'(cQ'&4$'&0#+&c(0#:'/1#"#(L&"#'/(1#A(H3/#46/A<('A"($6+(1'#(;'&1-&0(

%&( 1'#(2]L(1#+( Q'#/0#&#( @#+%&"53+"/'89( -&1(5'+1( 1%9#+( %/A(2]LI;'&1-&0A13*B&#(

g2;2h(:#,#'89&#"G(2'#A#+(L:A89&'""('A"(jj(L*'&3AB-+#&(0+3R(-&1(:#'(%//#&(&-4/#B+#&(

D#,#N"3+#&(A#9+(A"%+4(43&A#+@'#+"G(U#1#+(Q'&4$'&0#+(5'+1(%/A("#"+%#1+'A89#+(J3*N/#X(

%-A( #'&#*(Q'&4IY3&( -&1( _(=^A"#'&#&( 0#:'/1#"G(MD(:'&1#&( %/A(2'*#+( %&( #'&#(2]LI

!#r-#&,<(1'#(%/A(M/-8383+"'83'1ID#AN3&A#I./#*#&"(gMD.h(:#,#'89&#"(5'+1<(#'&#(N%I

/'&1+3*'A89#( !#r-#&,( @3&( P#( j( ]-4/#3"'1#&( gLMLL=L&&&ZMZZ=Zh<( 1'#( 1-+89( i(

]-4/#3"'1#(0#"+#&&"(A'&1G(U#5#'/A(#'&(MDIH3/#46/(:'&1#"(%&(#'&#()B/$"#(g)%+1(#"(%/G<(

affFs( C-'A'( #"( %/G<( affas(Q'//'%8-A(#"( %/G<( affkhG(2'#(0/#'89#(!#r-#&,(5'+1(%-89(@3&(

HD<(LD(-&1(>D(#+4%&&"<(5B9+#&1(.D(%&(#'&#(%&1#+#<(%:#+(@#+5%&1"#(N%/'&1+3*'I

A89#(2]LI!#r-#&,(:'&1#&G(2#+(#+A"#(Q'&4$'&0#+(#&"9B/"(L*'&3AB-+#&(,-+(.+4#&&-&0(

1#+(AN#,'$'A89#&(!#r-#&,(-&1(5'+1(%/A(>I;3X(:#,#'89&#"G(2#+(EG(Q'&4$'&0#+('A"($6+(1'#(

2'*#+'A'#+-&0( @#+%&"53+"/'89( -&1(5'+1( 1%9#+(2I;3X(0#&%&&"G(L-R#+1#*(#&"9B/"( 1'#(

2;2( %&( '9+#*(=I"#+*'&%/#&( .&1#( &389( !'0&%/A"+-4"-+#&( $6+( 1'#( Z+%&A/34%"'3&( 1#A(

D#,#N"3+A('&(1#&(Q#//4#+&(g>'8%+1(#"(%/G<(afb`hG(

'''''$U4N'''''''!>&'( ('''''''$U4E' 2;2

E' SSS

%' 3'

-=89D8H5:W:6=G9@'&%$4>:9IG9@'!:@89I69B:9IG9@'%GHA6`=6'!CH8A:D85:C9&:<6=:D:6=G9@'>:9IG9@'WC9'ZDL'

!""#$%&$!"#$%&'#())(* +',-#(#* .(/* 012!3* 012!* 4(/%(0%* 5"/* 6* 7&80%&9(#* :(;(&<80(#=*7()80(*.&(*%;5#/$;&>%&'#())(*?$%&@&(;"#9*A?!B=*.&(*+C?<:&#."#9*A+:+B*"#.*.&(*D&95#.(#4&#."#9*AD:+B*4(7&;$(#3*+5;&#*E&#.(#*/&80*4(/%&,,%(*2(<9&'#(#=*.&(*EF;*.&(*#"$)(-;(*D'$5)&/5%&'#=*.&(*+&,(;&/&(;"#9*"#.*.&(*:&#."#9*@'#*G&%H(/80'8$>;'%(&#(#*A0/>B*@(;5#%7';%)&80*/&#.3*

Page 17: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

E'*"%!*"-0%#' ' S'

S%AA#+*3/#46/( g;+,3,35A4'( #"( %/G<( aff`s( S'//'%*A( #"( %/G<( affbs( >'4#( #"( %/G<( afffs(

;/#1A3#(#"(%/G<(EFFEhG(2'#(#+A"#(L*'&3AB-+#('A"(#'&(L+0'&'&(@3&(9MD<(9.D(-&1(9>D<(

1%A( :#'( 1#+( 0%&,#&( !"#+3'193+*3&ID#,#N"3+I7%*'/'#( 43&A#+@'#+"( 'A"( g#&"AN+#89#&1(

L+0Ijaa('&(9MD!hG(2'#(,5#'"#(L*'&3AB-+#('A"(#'&(M/-"%*%"(:#'(9.D(-&1(#'&(M/-"%*'&(

'*(9>D(-&1(9MDG(L//#(D#,#N"3+#&($6+(!"#+3'1#(*'"(#'&#+(=iI=%+:3&^/$-&4"'3&(:#A'"I

,#&('&(1#+(#&"AN+#89#&1#&(>3A'"'3&(#'&(M/-"%*'&(gM/&Ik`F('&(9MD!hG(

!"+-4"-+#&( @3&( 9.D( '*( J3*N/#X(*'"( @#+A89'#1#&#&( C'0%&1#&( ,#'0#&<( 1%AA( 1'#( C'I

0%&1#&:'&1-&0A"%A89#( '&( 1#+( ]B9#( 1#A( 2ID'&0A( #'&#( +#/%"'@( 0+3R#( >/%A"','"B"( %-$I

5#'A"( -&1( '&(L:9B&0'04#'"( @3*(C'0%&1#&( @#+A89'#1#&#(J3&$3+*%"'3&#&(#'&&#9*#&(

4%&&G(Y&(5'#(5#'"(1'#A(:#'(%&1#+#&(!"#+3'193+*3&ID#,#N"3+#&(1#+(7%//('A"<(*-AA(&389(

-&"#+A-89"(5#+1#&(gJ-*%+(#"(%/G<(afffhG((

(

(

EFEFR'15=GH5G=a[:=HG9@D4>6K:6ZG9@69'I6='#AGJCJC=5:JC:I6'

(

K#+A89'#1#&#($-&4"'3&#//#(M+-NN#&(-&1(H31'$'4%"'3&#&(1#A(!"#+3'10#+6A"#A(#+*O0/'I

89#&(#'&#( A#/#4"'@#(;'&1-&0(%&(1'#( @#+A89'#1#&#&(!"#+3'193+*3&ID#,#N"3+#&G(2#+(

>DIC'0%&1(>+30#A"#+3&(:'&1#"(%&(9MD!(&-+(*'"(&'#1+'0#+(L$$'&'"B"G()^1+3X^/'#+-&0#&(

'&(>3A'"'3&(aa<( a`(-&1(Ea( $69+#&( ,-*(=3+"'A3/<( 1#*(5'89"'0A"#&(M/-8383+"'83'1(1#A(

H#&A89#&(gVP%A33(#"(%/G<(afbbhG(2'#(J+'A"%//A"+-4"-+(1#+(9MD!IC;2(5#'A"(%-$(#'&(-*I

$%&0+#'89#A(S%AA#+A"3$$:+684#&&#",5#+4(,5'A89#&(1#&()^1+3X^/0+-NN#&(1#+(M/-83I

83+"'83'1#(-&1(1#*(9MD!(9'&(g;/#1A3#(#"(%/G<(EFFEhG(M+3R#(t9&/'894#'"(:#A"#9"(,5'I

A89#&( M/-8383+"'83'1#&( -&1( H'&#+%/383+"'83'1#&<( 1%9#+( 6:#+/%NN#&( %-89( 1'#(

L$$'&'"B"#&($6+(1'#(D#,#N"3+#&G(9HD(:'&1#"(&%9#,-(%//#(M/-8383+"'83'1#(-&1(H'&#+%/3I

83+"'83'1#<(5B9+#&1(1%A(H'&#+%/383+"'83'1(L/13A"#+3&(&-+(#'&#(A#9+(0#+'&0#(L$$'&'"B"(

,-*(9MD!(:#A'","(gD-NN+#89"(#"(%/G<(affihG((

(

(

(

(

(

(

Page 18: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

X'' ' E'*"%!*"-0%#'

(

(

(

(

(

(

(

(

(

(

(

.'&( $6+( 1'#( Z9#+%N'#( *'"( M/-8383+"'83'1#&( #&"A89#'1#&1#+( K3+"#'/( 0#/%&0( 1-+89( 1'#(

2'$$#+#&,'#+-&0(@3&(*'&#+%/383+"'83'1#&(-&1(0/-8383+"'83'1#&(S'+4-&0#&(1-+89(.'&I

$69+-&0(#'&#+(,5#'"#&(23NN#/:'&1-&0(,5'A89#&(>3A'"'3&(a(-&1(E('&(D'&0(L(1#A(=3+"'I

A3/A( gL::G( ih( g!9+33"( #"( %/G<( afbEhG( 2%A( 1%+%-A( +#A-/"'#+#&1#( >+#1&'A3/3&( g>2h( 'A"(

@'#+$%89( A"B+4#+( 0/-8383+"'83'1( -&1( &-+( Eli( A3( A"%+4( *'&#+%/383+"'83'1( 5'+4A%*( 5'#(

=3+"'A3/G(.'&#()%/30#&'#+-&0('&(>3A'"'3&(f!(-&1(j!(#+9O9"(1'#(L$$'&'"B"(,-(9MD!(,-I

AB",/'89<(&389(%-A0#N+B0"#+(P#1389(1'#(;'&1-&0(%&(9HDG(2-+89(.'&$69+-&0(#'&#+(5#'I

"#+#&(H#"9^/I(31#+()^1+3X^/0+-NN#('&(>3A'"'3&(aj(A"#'0"(1%0#0#&(1'#(M/-8383+"'83'1I

S'+4-&0(&389*%/A<(:#'(0/#'89,#'"'0#+($%A"(@3//A"B&1'0#+(./'*'&%"'3&(1#+(*'&#+%/383+"'I

83'1#&(.$$#4"#(g2%9/:#+0(#"(%/G<(afb_hG(2-+89()%/30#&'#+-&0('&(>3A'"'3&(f(-&1l31#+(j(

-&1( 0/#'89,#'"'0#( H#"9^/'#+-&0( 31#+( )^1+3X^/'#+-&0( '&( >3A'"'3&( aj( 4O&&#&( %/A3((

L+,&#'A"3$$#( *'"( A#9+( A"%+4#+( L$$'&'"B"( ,-*( 9MD!( -&1( @#+&%89/BAA'0:%+#+( 9HDI

;'&1-&0(#++#'89"(5#+1#&(g;+%""A%&1(#"(%/G<(afbEs(2%9/:#+0(#"(%/G<(afb_s(D-NN+#89"(#"(

%/G<(affihG((

;#A3&1#+A( $6+(1'#( "3N'A89#(Z9#+%N'#( 'A"(%-89(1'#(!^&"9#A#(@3&(.A"#+I2#+'@%"#&(1#+(

M/-8383+"'83'1#('&"#+#AA%&"<(1%(1-+89(1'#(#+9O9"#(C'N3N9'/'#(#'&#(:#AA#+#(/34%/#(>#I

&#"+%"'3&(#++#'89"(5#+1#&(4%&&(gM^A/#+(#"(%/G<(afffhG(.'&#(K#+#A"#+-&0('&(>3A'"'3&(a`(

1#+(!"#+3'1#(#+9O9"(0/#'89,#'"'0(1'#(L$$'&'"B"(,-*(9MD!<(5B9+#&1(#'&#(K#+#A"#+-&0('&(

>3A'"'3&(Ea(P#(&%89(CB&0#(1#A(!B-+#I!-:A"'"-#&"#&(1'#(;'&1-&0A%$$'&'"B"(*#9+(31#+(

5#&'0#+( A"%+4(#+&'#1+'0"G( 76+(M/-8383+"'83'1I23NN#/#A"#+(5-+1#(%/A3(#'&#(D#,#N"3+I

:'&1-&0(1#"#4"'#+"<(1'#(,5'A89#&(1#&(a`I(-&1(1#&(EaI.A"#+&(/'#0"(g>3&#8(#"(%/G<(afbas(

!9+33"(#"(%/G<(afbEs(>3&#8(#"(%/G<(afbjs(>O+"&#+(#"(%/G<(afbbhG((

!""#$'&$I%;"$%";*.(/*J';%&/')/*AGK.;'8';%&/'#B3*L'/&%&'#(#*.(;(#*M'.&E&$5%&'#*H"*(&<#(;* N#.(;"#9* .(;* ?EE&#&%-%* "#.* I()($%&@&%-%* EF;* .(#* 012!* EF0;%(* /&#.* ,&%*C",,(;#*4(H(&80#(%3*

V

V)V)

V V)

&3

>$'

Ea(

a`(aj(

f(

j(

a(E(

Page 19: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

E'*"%!*"-0%#' ' P'

EFN' 1:@98A5=89DIGH5:C9'OB6='I69'#AGJCJC=5:JC:I4)6K6L5C='(

2#+( '&%4"'@#( 9MD!( :#$'&1#"( A'89( '*( Q^"3A3/( -&1( /'#0"( 13+"( %&( )'",#A89384N+3"#'&#(

g9ANh( 0#:-&1#&( @3+G(H#'A"( A'&1( %&( 1'#A#*(J3*N/#X( #'&( 9ANfF(2'*#+<(5#'"#+#( 9AN(

-&1(Y**-&3N9'/'&#(:#"#'/'0"(g>+%""(#"(%/G<(aff`hG(2'#(9AN(A'&1(=9%N#+3&#<(1'#(1'#(43+I

+#4"#(7%/"-&0( 1#A(>+3"#'&A( 0#5B9+/#'A"#&<( -&1( 1%*'"( 1'#( C'0%&1#&:'&1-&0(#+*O0/'I

89#&G(L&1#+A#'"A(9%/"#&(A'#(1#&(9MD!( '*('&%4"'@#&(Q-A"%&1('*(Q^"3A3/(g>+%""(#"(%/G<(

afffhG(;#'(;'&1-&0(#'&#A(M/-8383+"'83'1A(1'AA3,''#+"(1-+89(#'&#(J3&$3+*%"'3&AB&1#I

+-&0(1#A(D#,#N"3+N+3"#'&A(1#+(9MDI9ANIJ3*N/#X(-&1(1#+(D#,#N"3+(#+/%&0"(1'#(7BI

9'04#'"(,-+(2'*#+'A'#+-&0(g;%*:#+0#+(#"(%/G<(affjs(;/#1A3#(#"(%/G<(EFFEhG(2#A(5#'"#I

+#&(0#/%&0#&($6+(1#&(W:#+0%&0(1#A(D#,#N"3+A('&(1#&(Q#//4#+&(5'89"'0#(23*B&#&(%&(

1'#( V:#+A#'"#( 1#A( D#,#N"3+N+3"#'&A<( 1'#( 1%+%-$9'&( *'"( AN#,'$'A89#&( >+3"#'&#&( 1#+(

J#+&N3+#&( '&(J3&"%4"( "+#"#&(g>'8%+1(#"(%/G<(afb`s(S'4A"+3*(#"(%/G<(afb`s(M%A8(#"(%/G<(

afbfs(=%1#N3&1(#"(%/G<(affEhG(2#+( /'0%&1#&%4"'@'#+"#(9MD!(5%&1#+"( '&(1#&(Q#//4#+&(

-&1( 4%&&( 13+"( %-$( ,5#'( -&"#+A89'#1/'89#( L+"#&( 1'#(M#&#XN+#AA'3&( +#0-/'#+#&G( Q-*(

#'&#&(5'+1(&%89(2]LI;'&1-&0(1'#(Z+%&A4+'N"'3&(AN#,'$'A89#+(Q'#/0#&#(%4"'@'#+"(31#+(

+#N+'*'#+"<($#+&#+(4%&&(1-+89(Y&"#+%4"'3&(*'"(:#A"'**"#&(Z+%&A4+'N"'3&A$%4"3+#&(1#+#&(

L4"'@'"B"( 0#9#**"( 5#+1#&( g;%+&#A<( affbs( MO""/'89#+( #"( %/G<( affbs( S#:A"#+( #"( %/G<(

afffhG(

(

(

EFNFE'-=89DH=:L5:C96AA6'$H5:W:6=G9@'G9I';6<<G9@'WC9'#6969'IG=JZ'&%$4>:9IG9@'I6D'#AGJCJC=5:JC:I4)6K6L5C=D'

(

2'#("+%&A4+'N"'3&#//#(L4"'@'#+-&0(@3&(Q'#/0#&#&(A"#//"(1#&(4/%AA'A89#&(S'+4*#89%&'AI

*-A( 1#+( !"#+3'193+*3&#( 6:#+( &-4/#B+#(D#,#N"3+#&( 1%+G( .'&()3*31'*#+( %-A( ,5#'(

%4"'@'#+"#&(9MD!(:'&1#"(1'#(AN#,'$'A89#(.+4#&&-&0AA#r-#&,<(1%A(MD.('&(1#+(2]LG(

2'#(L7IaIZ+%&A%4"'@'#+-&0A13*B&#(4%&&(&-&(*'"(:%A%/#&(Z+%&A4+'N"'3&A$%4"3+#&(5'#(

1#+( D]LI>3/^*#+%A#( YY<( 1#*( ZLZLI;'&1-&0AI>+3"#'&( gZ;>h( 31#+( 1#*( Z;>I

LAA3,''#+"#&I7%4"3+( gZL7h( '&"#+%0'#+#&( -&1( 1#+#&( L4"'@'"B"( #+9O9#&( g;%*:#+0#+( #"(

%/G<(affjs(L18384<(EFFFhG(Q-+(K#+A"B+4-&0(1#+(M#&%4"'@'#+-&0(A'&1(Y&"#+%4"'3&#&(*'"(

5#'"#+#&(J3%4"'@%"3+#&(5'89"'0(gL::G(_h(gH8J#&&%(#"(%/G<(afffhG((

Page 20: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

E^'' ' E'*"%!*"-0%#'

76+(#'&#(M#&%4"'@'#+-&0(:#1#-"A%*#(J3$%4"3+#&(A'&1(1%A(8LH>ID#AN3&A#I./#*#&"I

;'&1-&0A$%4"3+I(g=D.;Ih(;'&1'&0I>+3"#'&(g=;>h(-&1(1%A(@#+5%&1"#(NiFF(gU%&4&#89"(

#"(%/G<(affjs(J%*#'(#"(%/G<(affjhG(2'#A#(%8#"^/'#+#&()'A"3&N+3"#'&#(-&1(:#5'+4#&(1%I

9#+(&%89(;'&1-&0(%&(%4"'@'#+"#(9MD!(31#+(,%9/+#'89#(%&1#+#(Z+%&A4+'N"'3&A$%4"3+#&(

#'&#( .&"AN'+%/'A'#+-&0( 1#+( '*( D-9#,-A"%&1( 1'89"( 0#N%84"#&( =9+3*%"'&A"+-4"-+G( 2'#(

L-$/OA-&0(1#+(]-4/#3A3*#&(#+/#'89"#+"(1'#(;'&1-&0(1#+(:%A%/#&(Z+%&A4+'N"'3&A$%4"3I

+#&(-&1(1%*'"(1'#(L4"'@'#+-&0(1#+(>+3*3"3+#&(gJ%*#'(#"(%/G<(affjs(Y*93$(#"(%/G<(affbhG((

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

2'#( Y&"#+%4"'3&( 1#A( 9MD!( *'"( =;>lNiFF( #+$3/0"( #&"5#1#+( 1'+#4"( 31#+( 6:#+( %&1#+#(

&-4/#B+#(J3%4"'@%"3+#&<(5'#( 1#&(!"#+3'1ID#8#N"3+I=3%8"'@%"3+Ia( g!D=Iah( gV&%"#( #"(

%/G<( affkh<( 1#&( !'0&%/IZ+%&A1-8#+I%&1IL8"'@%"3+I3$IZ+%&A8+'N"'3&Ik( g!ZLZIkh( 31#+(

!""#$(&*M(805#&/,"/*.(;*012!<@(;,&%%()%(#*?$%&@&(;"#9*@'#*O&()9(#(#3*+&(*&,*2"<0(H"/%5#.* 5#* G&%H(/80'8$>;'%(&#(* A0/>PQB* 9(4"#.(#(#* 012!* 75#.(;#*#580*?$%&@&(;"#9*.";80*1)"8'8';%&8'&.(*&#*.(#*O())$(;#=*&#%(;59&(;(#*.';%*,&%*12R*.(;*+C?*"#.* &#&%&&(;(#*.&(*S;5#/$;&>%&'#/5$%&@&(;"#9*.";80*T#%(;5$%&'#*,&%* 45/5)(#* S;5#/$;&>%&'#/E5$%';(#* 7&(* 2C?<L')K,(;5/(*TT=* S?S?<:&#."#9/<L;'%(&#*AS:LB*"#.*S:L<?//'H&&(;%(;<!5$%';*AS?!B*"#.*U'5$%&@5%'<;(#* 7&(* I%(;'&.<2(8(>%';<J'58%&@5%';* AI2JB* "#.* J2R:<:&#.&#9<L;'%(&#*AJ:LB*A#580*:5,4(;9(;*(%*5)3=*VPPWX*?.8'8$*(%*5)3=*YQQQB3*

ZDLP^'

ZDLP^'

(

(

+Q5CLA8D<8'

%GHA6GD'

&%$'

#) #) #)

#!03.3.)-"3."&'

-=89DH=:L5:C9'

ZDLP^'#)'ZDLP^'

#)*'

()%$4,CAQ4<6=8D6'""'

-$U

3>, ->,#)

1)3#)'

Page 21: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

E'*"%!*"-0%#' ' EE'

1#&(Z+%&A8+'N"'3&$%8"3+IY&"#+*#1'%+^I7%8"3+IE(gZY7IEh(g2'&0(#"(%/G<(affbs(H8J#&&%(#"(

%/G<(afffs(D#$3P3(#"(%/G<(EFFas(!"#'&*#",(#"(%/G<(EFFahG(L//#(1'#A#(J3%4"'@%"3+#&(:#A'"I

,#&(#'&#(%/A(]DI;3X(:#,#'89&#"#(!#r-#&,(C[[CC(gC(A"#9"($6+(C^A'&<([($6+(P#1#(:#/'#I

:'0#(L*'&3AB-+#h<(6:#+(1'#(A'#(*'"(1#+(L7IEI23*B&#(1#A(MD( '&(K#+:'&1-&0( "+#"#&(

g)##+^(#"(%/G<(aff`hG((

2'#(#+9O9"#(Z+%&A4+'N"'3&A+%"#(1#+(M/-8383+"'83'1I+#AN3&A'@#&(M#&#($69+"(,-+(Z+%&AI

/%"'3&(-&1(#'&#+(@#+*#9+"#&(;'/1-&0(1#+(Q'#/N+3"#'&#G(2'#(*#'A"#&(6:#+(1'#(4/%AA'A89#(

Z+%&A%4"'@'#+-&0( @#+*'""#/"#&( M/-8383+"'83'1IS'+4-&0#&( 1'#&#&( 1#+( D#0-/%"'3&( @3&(

*#"%:3/'A89( -&1( 4%+1'3@%A4-/B+( +#/#@%&"#&( M#&#&( g;%*:#+0#+( #"( %/G<( aff`s( )%",<(

affbhG(.A(5#+1#&(%:#+(%-89(#'&'0#(%&"''&$/%**%"3+'A89(5'+4#&1#(>+3"#'&#(@#+A"B+4"(

0#:'/1#"<( 5'#( ,G( ;G( C'N383+"'&<( Y&"#+/#-4'&IaID#,#N"3+( -&1( 1%A( Y&9':'"3+N+3"#'&( 1#A(

&-4/#B+#&(7%4"3+A(#;(gY#;!h(g;%+&#A<(affbs(L18384<(EFFFhG(.'&#(@#+*#9+"#(!^&"9#I

A#(AN#,'$'A89#+(D':3&-4/#%A#&(4%&&(,-1#*(1#&(L::%-(:#A"'**"#+(*D]L(:#A89/#-I

&'0#&(-&1(1%9#+(1'#(;'/1-&0(@3&(#&",6&1-&0A+#/#@%&"#&(>+3"#'&#&(+#1-,'#+#&G(;#3I

:%89"#"(5-+1#(1'#A($6+(1#&(M+%&-/3,^"#&lH%4+3N9%0#&IJ3/3&'#A"'*-/'#+#&1#&(7%4"3+(

gMHI=!7h(-&1(1'#( '&1-,'#+:%+#(=^8/33X^0#&%A#IE(g=V[IEh(gD'A"'*%4'(#"(%/G<(affjhG(

2#A( 5#'"#+#&( 5-+1#( 1'#( LN3N"3A#'&1-4"'3&( 1-+89( M/-8383+"'83'1#( :#'( ZIQ#//#&( %-$(

#'&#( 7O+1#+-&0( 1#+( M#&#XN+#AA'3&( ,-+6840#$69+"<( 1%( M/-8383+"'83'1#( :#'( ZIQ#//#&(

*'"( "+%&A%4"'@'#+-&0A1#$','#&"#*( MD( &'89"( '&( 1#+( C%0#( A'&1<( LN3N"3A#( %-A,-/OA#&(

gD%*1%A(#"(%/G<(affbs(D#'89%+1"(#"(%/G<(affbh(

2-+89(;'&1-&0(%&(#'&#(AN#,'$'A89#(2]LI!#r-#&,('A"('&(.'&,#/$B//#&(%-89(#'&#(&#0%I

"'@#(M#&+#0-/%"'3&(*O0/'89(gS#:A"#+(#"(%/G<(afffhG(]#0%"'@#(MD.(-&"#+A89#'1#&(A'89(

@3&(1#&(N3A'"'@#&(-&1(5-+1#&(,G;G( '&(1#&(>+3*3"3+#&(1#+(M#&#($6+(1%A(=3+"'83"+3I

N'&ID#/#%A'&0I)3+*3&( gH%/43A4'( #"( %/G<( aff`h( -&1( 1#&( K%A3%4"'@#&IY&"#A"'&%/I

>3/^N#N"'1ID#,#N"3+(g>#'<(affjh(0#$-&1#&G(.'&#(5#'"#+#(HO0/'894#'"(1#+(M#&+#N+#AI

A'3&(1-+89(AN#,'$'A89#(2]LI;'&1-&0(1#A(9MD!('A"(#'&#(6:#+/%NN#&1#(;'&1-&0AA"#//#(

1#A( 9MD!( *'"( 1#&( ZLZLI;3X( ./#*#&"#&( #'&#A( >+3*3"3+AG( 2%&&( 'A"( :#'( ;'&1-&0((

#'&#A( %4"'@'#+"#&( 9MD!( %&( AN#,'$'A89#( 2]LI.+4#&&-&0AA#r-#&,#&( 4#'&#( ;'&1-&0(

1#A(Z;>(-&1(5#'"#+#+($6+(1'#(M#&%4"'@'#+-&0(5'89"'0#+(:%A%/#+(Z+%&A4+'N"'3&A$%4"3+#&(

*#9+(*O0/'89G(.'&(;#'AN'#/($6+(1'#A#(L+"(1#+(M/-8383+"'83'1(@#+*'""#/"#&(M#&+#N+#AA'I

3&('A"(1%A(VA"#38%/8'&(M#&(gH#^#+(#"(%/G<(aff`hG(

(

(

Page 22: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

EN'' ' E'*"%!*"-0%#'

EFNFN';6<<G9@' WC9' -=89DH=:L5:C9D78H5C=69' IG=JZ' I69' #AGJCJC=5:4JC:I4)6K6L5C='b-=89D=6L=6DD:C9c'

(

M/-8383+"'83'1#(:##'&$/-AA#&(%:#+(%-89(#'&#(0+3R#(Q%9/(@3&(9%-N"AB89/'89('**-&3I

/30'A89( :#1#-"A%*#&( M#&#&<( '&( 1#+#&( >+3*3"3+A#r-#&,#&( 4#'&( MD.( @3+43**"(

gMO""/'89#+( #"( %/G<( affbhG( K'#/#( 1'#A#+( M#&#( 5#+1#&( 1-+89( N+3'&$/%**%"3+'A89#(

Z+%&A4+'N"'3&A$%4"3+#&(+#0-/'#+"<(5'#(,-*(;#'AN'#/(1-+89(1%A(L4"'@%"3+N+3"#'&(a(gL>Iah(

:#A"#9#&1( %-A( 1#&( ?&"#+#'&9#'"#&( 8I73A( -&1( 8IU-&( gJ%+'&( #"( %/G<( EFFah( -&1( 1#&(

&-4/#B+#&(7%4"3+(#;(g]7#;h(:#A"#9#&1(%-A(1#&(NkF(-&1(Njk(?&"#+#'&9#'"#&(gL/*%5'(

#"(%/G<(EFFE%hG(

]7#;(:#$'&1#"( A'89( '*( '&%4"'@#&(!"%1'-*( '*(Q^"3A3/(-&1( 'A"(13+"( '&(#'&#*(J3*N/#X(

*'"( 1#*( Y&9':'"3+N+3"#'&( Y#;!( 0#:-&1#&G( Q-+( ]7#;( L4"'@'#+-&0( 43**"( #A<( '&1#*(

Y#;!(N93AN93+^/'#+"<(%&A89/'#R#&1(-:'r-'"'&^/'#+"(-&1(@3*(>+3"#%A3*43*N/#X(%:0#I

:%-"( 5'+1( gH8J%^( #"( %/G<( afffhG( L/A( H#89%&'A*-A( 1#+( M/-8383+"'83'1( @#+*'""#/"#&(

]7#;I)#**-&0(5-+1#(,-&B89A"(:#'(U-+4%"(Q#//#&(gZIQ#//(C^*N93*h(-&1(H3&3,^"#&(

#'&#(Y&1-4"'3&(1#A(Y#;!I>+3"#'&A(:#3:%89"#"(gL-N9%&(#"(%/G<(affks(!89#'&*%&(#"(%/G<(

affkhG(2%1-+89(5'+1(]7#;('*('&%4"'@#&(Q-A"%&1('*(Q^"3A3/(0#9%/"#&(-&1(A3(%&(1#+(

2]LI;'&1-&0(-&1(M#&%4"'@'#+-&0(0#9'&1#+"G(;#'(*-+'&#&(7':+3:/%A"#&(-&1(N+'*B+#&(

9-*%&#&( 7':+3:/%A"#&( 9'&0#0#&( 5-+1#( #'&#( )#**-&0( 1#+( Y&"#+/#-4'&I(gYCIh(jI

.XN+#AA'3&(-&1(1#+(Njk(%:9B&0'0#&("+%&A4+'N"'3&#//#&(L4"'@'#+-&0(1-+89(M/-8383+"'I

83'1#( :#3:%89"#"<( 39&#( 1%AA( 1#+( Y#;!IM#9%/"<( 1'#( C34%/'A%"'3&( 31#+( 1'#( 2]LI

;'&1-&0(@3&(]7#;(@#+B&1#+"(5-+1#(g2#(;3AA89#+(#"(%/G<(aff`hG((

.'&#(*O0/'89#(.+4/B+-&0('A"(1'#()#**-&0(1#+(]7#;IL4"'@'#+-&0(%-$0+-&1(#'&#+(J3&I

4-++#&,(-*($6+(1'#(M#&%4"'@'#+-&0(5'89"'0#<(%:#+(/'*'"'#+"#(J3$%4"3+#&(5'#(=;>lNiFF(

31#+(!D=Ia(g!9#NN%+1(#"(%/G<(affbh(gL::G(k;hG( Y&(%&1#+#&(!^A"#*#&(5-+1#( P#1389(

#'&#()#**-&0(1#+(]7#;(M#&%4"'@'#+-&0(-&%:9B&0'0(@3&(1#&('&(1#&(Q#//#&(@3+9%&I

1#&#&(J3$%4"3+IH#&0#&(&%890#5'#A#&( g2#(;3AA89#+( #"( %/G<( EFFFhG(2#+#&(?+A%89#(

43&&"#(%-$(#'&#(1'+#4"#(S#89A#/5'+4-&0(1#+(%4"'@'#+"#&(MD(*'"(1#+(NjkI?&"#+#'&9#'"(

31#+(%&1#+#&(:%A%/#&(Z+%&A4+'N"'3&A$%4"3+#&('&(1#+(ZLZLI;3X(?*0#:-&0(,-+6840#I

$69+"( 5#+1#&( gL::G( k=h<( #'&#( ,-AB",/'89#( D#4+-"'#+-&0( @3&( J3+#N+#AA3+#&( 5-+1#((

#:#&$%//A(:#A89+'#:#&(gL::G(k2h(gL/*%5'(#"(%/G<(EFFE%hG((

(

Page 23: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

E'*"%!*"-0%#' ' EM'

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

(

]#:#&( ]7#;( -&1( L>Ia( A'&1( 1#+( V8"%*#+IZ+%&A4+'N"'3&AI7%4"3+Ia( gV8"Iah<( 1%A(

==LLZI.&9%&8#+I;'&1'&0I>+3"#'&( g=l.;>h( -&1( 1#+( 8LH>ID#AN3&A#I./#*#&"I

;'&1-&0A$%4"3+(g=D.;h(5#'"#+#(7%4"3+#&<(1#+#&(Z+%&A4+'N"'3&(1-+89(9MD!(0#9#**"(

5'+1(gL18384<(EFFas(L18384(#"(%/G<(EFFas(D#$3P3(#"(%/G<(EFFahG(2#A(5#'"#+#&('&9':'#+#&(

M/-8383+"'83'1#( 1'#( !'0&%/6:#+"+%0-&0( 1#A( ]-8/#%+I7%8"3+I3$IL8"'@%"#1IZI=#//A(

g]7LZh<( '&1#*( A'#( 1'#( ,-+( M#&%4"'@'#+-&0( &O"'0#( 433N#+%"'@#( ;'&1-&0( 1#A((

Z+%&A4+'N""'3&A$%4"3+A( %&( L>Ia( :##'&"+B89"'0#&( gD#$3P3( #"( %/G<( EFFahG( 2'#( Z+%&AI

+#N+#AA'3&(@3&(J3$%4"3+#&(5'+1(9#-"#(%/A(5'89"'0A"#+(H#89%&'A*-A(1#+(%&"''&$/%**%I

"3+'A89#&(-&1('**-&3/30'A89#&(M/-8383+"'83'1IS'+4-&0(%&0#&3**#&G(.A(43**"(,-+(

)#**-&0( 1#+( .XN+#AA'3&( #'&#+( 0+3R#&( Q%9/( @3&( N+3'&$/%**%"3+'A89#&( Q^"34'&#&(

gYCIa<( IE<( Ii<( I_<( Ik<( Ij<( Iaa<( IaE<( Iai<( Z]7!<(MHI=!7h<(=9#*34'&#&( gYCIb<(D%&"#A<(

>-U'

-=89DH=:L5:C9

#>'D:56$ >-U'LYT' LT^'

/$'

$'

/$'#)'

#>'D:56$ >-U'LYT' LT^'

/6:96'-=89DH=:L5:C9'

>'

3'

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

#>'D:56

/6:96'>:9IG9@'

LYT' LT^'

#) /6:96'-=89DH=:L5:C9'

&

#>'D:56 >-U'LYT' LT^'

#)

/6:96'-=89DH=:L5:C9'

/)

Page 24: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

ER'' ' E'*"%!*"-0%#'

H=>Ia<(Ii<(I_h(-&1(L19BA'3&A*3/#46/#&(gY=LHIa<(.I!#/#8"'&h(g;%+&#A<(affbs(L/*%5'(

#"(%/G<(EFFE:hG(]#-#+#(;#3:%89"-&0#&(,#'0#&(%-89(1'#(;#1#-"-&0(1#+(Z+%&A+#N+#AI

A'3&( $6+( N+3%N3N"3"'A89#(-&1(%&"'N+3/'$#+%"'@#(M/-8383+"'83'1IS'+4-&0#&<( A3( 43&&"#&(

:'A9#+(4#'&#(N+3%N3N"3"'A89#&(M#&#(*'"(MD.('1#&"'$','#+"(5#+1#&<(1#+(M/-8383+"'83'1I

'&1-,'#+"#&( LN3N"3A#( @3&( ZIQ#//#&( 0#9"( %//#+1'&0A( #'&#( !-NN+#AA'3&( 1#A( $6+( 1%A((

W:#+/#:#&( -&1( 1'#( >+3/'$#+%"'3&( 5'89"'0#&( 7%4"3+A( 8I*^8( @3+%-A( g)#/*:#+0( #"( %/G<(

affks(M+##&A"#'&(#"(%/G<(EFFEhG((

2#+(@3&(1#+(2]LI;'&1-&0(-&%:9B&0'0#&(M#&+#N+#AA'3&(1-+89(M/-8383+"'83'1#(5'+1(

&#-#+1'&0A( :#A3&1#+#( ;#1#-"-&0( ,-0#AN+389#&G( K#+A-89#( %&( HB-A#&( *'"( #'&#+(

H-"%"'3&('&(1#+(2;2<(1'#(1'#(2'*#+'A'#+-&0(-&1(2]LI;'&1-&0(@3&(9MD!(@#+9'&1#+"<(

,#'0#&<(1%AA(1'#A#(HB-A#("+3",(#'&'0#+($-&4"'3&#//#+(!"O+-&0#&(6:#+/#:#&A$B9'0(A'&1<(

5B9+#&1(43*N/#""#(MDIJ&3843-"IHB-A#(4-+,(&%89(1#+(M#:-+"(%-$0+-&1(+#AN'+%"3+'I

A89#+(!"O+-&0#&(A"#+:#&(g)#84(#"(%/G<(aff_s(=3/#(#"(%/G<(affks(D#'89%+1"(#"(%/G<(affbhG(

(

(

EFM' #AGJCJC=5:JC:I4)6K6L5C=41GB5QL69'(

2%A(M#&($6+(1#&(9MD('A"(%-$(1#*(4-+,#&(L+*(1#A(=9+3*3A3*A(k(/34%/'A'#+"(-&1(:#I

A"#9"(%-A(aF(.X3&A(gL::G(jhG(L/"#+&%"'@#A(!N/#'R#&(1#+(>+'*B+ID]L('*(.X3&(f($69+"(

,-(E(!-:"^N#&(1#A(9MD<(1'#(%/A(9MD!(-&1(9MD"(:#,#'89&#"(5#+1#&(g)3//#&:#+0(#"(

%/G<(afbkhG((

;#'1#(D#,#N"3+I!-:"^N#&(A'&1('1#&"'A89(:'A(,-(L*'&3AB-+#(`E`<(9MD!(:#A'","(5#'"#I

+#(kF(L*'&3AB-+#&<(1'#(f!I!#r-#&,<(1'#(1'#( Y&$3+*%"'3&#&( $6+(1'#(:#4%&&"#(C'0%&I

1#&:'&1-&0A13*B&#(#&"9B/"G(9MD"(#&"9B/"(1'#(f"I!#r-#&,<(1'#(%-A(&-+(ak(5#'"#+#&(

&'89"( 93*3/30#&( L*'&3AB-+#&( :#A"#9"( -&1( 4#'&#( '&"%4"#( C'0%&1#&:'&1-&0AA"#//#(

%-$5#'A"(gL::G(`hG(9MD"('A"(1%9#+(&'89"('&(1#+(C%0#(M/-8383+"'83'1#(,-(:'&1#&G(

(

(

(

(

(

(

Page 25: Ligand - Rezeptor Interaktionen und Signaltransduktion von ... · &1$#0%#’ ’ 2""’ 7+%-(>+3$g(2+g(h3&’4%(!89b$#+ij3+"’&0(1%&4#(’89(a#9+(9#+,/’89($6+(1’#(k#+0%:#(1#a(’&"#+#aa%&"#&(2’aa#+"%"’3&a"9#*%a

E'*"%!*"-0%#' ' ET'

(

(

(

(

(

(

(

(

(

(

(

(

(

(

2'#(:#4%&&"#&(.$$#4"#(@3&(9MD!(5-+1#&('*(@3+%&0#0%&0#&#&(J%N'"#/(#+/B-"#+"<(1'#(

;#1#-"-&0(@3&(9MD"(1%0#0#&('A"(&%89(5'#(@3+(-&4/%+G(;%*:#+0#+(#"(%/G(g;%*:#+0#+(

#"(%/G<(affkh(#&"1#84"#&<(1%AA(9MD"(%/A(*O0/'89#+(13*'&%&"(&#0%"'@#+( Y&9':'"3+(%-$(

1'#(9MD!( @#+*'""#/"#&(.$$#4"#(5'+4"<(1'#(D#N+#AA'3&(1#+(9MD!I'&1-,'#+"#&(M#&%4"'I

@'#+-&0(5-+1#('&(#'&'0#&(Q#//A^A"#*#&(:#3:%89"#"G(S#'"#+#(?&"#+A-89-&0#&(,#'0"#&<(

1%AA(9MD"( '&(1#+(C%0#('A"(%&(9AN(-&1(MD.(,-(:'&1#&<(#A(5-+1#(1'#(;'/1-&0(#'&#A(

)#"#+31'*#+A(%-A(9MD!(-&1(9MD"(N3A"-/'#+"(gV%4/#^(#"(%/G<(afffh(gL::G(`hG(L&1#+#(

L+:#'"A0+-NN#&( 1'A4-"'#+#&( 1'#( .+0#:&'AA#( %-A( D#N3+"#+0#&@#+A-89#&( P#1389( 43&I

"+3@#+A(g)#89"(#"(%/G<(aff`s(=%+/A"#1"I2-4#<(afffs(K3""#+3(#"(%/G<(afffhG((

(

(

(

(

(

(

(

(

(

(

( P"$P!XSYTR'M'N'E' Md'Td'

Z#)!',=C56:9e'SSS'$1' Z#)"',=C56:9e'SRN'$1'%' 3'%'3'

"&' &>&' !>&' "&' &>&' d!>&d'

!""#$*&*R#%/%(0"#9*.(;*Y*012<I>)(&`@5;&5#%(#*5"/*.(,*012<1(#3*:(&.(*2(H(>%';<I"4%K>(#*4(/%(0(#*5"/*.(#*?,&#'/-";(#*@'#*a*&.(#%&/80(#*R['#/*"#.*.(,#("#%(#=*/>(H&E&/80(#*R['#*A#580*:5,4(;9(;*(%*5)3=*VPPWB3*


Recommended